C07K 2317/624
Disulfide-stabilized antibody
Official title: Disulfide-stabilized antibody (dsFv)
C07K2317/624 (Disulfide-stabilized antibody) appears on 244 US grants and 414 published applications in this corpus.
Search patents in C07K- Granted patents
- 244
- Published applications
- 414
- Assignees
- 190
- Inventors
- 861
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 2 |
| 2003 | 2 | 4 |
| 2004 | 1 | 3 |
| 2005 | 0 | 6 |
| 2006 | 1 | 6 |
| 2007 | 1 | 5 |
| 2008 | 3 | 4 |
| 2009 | 3 | 11 |
| 2010 | 6 | 5 |
| 2011 | 7 | 15 |
| 2012 | 3 | 17 |
| 2013 | 7 | 19 |
| 2014 | 5 | 15 |
| 2015 | 9 | 24 |
| 2016 | 21 | 39 |
| 2017 | 21 | 31 |
| 2018 | 23 | 31 |
| 2019 | 16 | 23 |
| 2020 | 22 | 40 |
| 2021 | 19 | 31 |
| 2022 | 17 | 17 |
| 2023 | 10 | 20 |
| 2024 | 11 | 19 |
| 2025 | 17 | 16 |
| 2026 | 8 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- 4-1BBL trimer-containing antigen binding molecules1 Sep 2026US 12,723,084 B2Hoffmann-La Roche Inc.
- Anti-Nogo-A antibodies and methods of making and using thereof23 Jun 2026US 12,662,528 B2NovaGo Therapeutics AG
- Compositions and methods for inhibition of MICA/B shedding23 Jun 2026US 12,662,540 B2Dana-Farber Cancer Institute, Inc.
- Anti-ROR1 / anti-CD3 bispecific binding molecules16 Jun 2026US 12,655,217 B2VelosBio Inc.
- IgM Fc and j-chain mutations that affect IgM serum half-life9 Jun 2026US 12,649,791 B2IGM Biosciences, Inc.
- Engineered Antibodies and Uses Thereof8 Oct 2026US 2026/0308277 A1Invitrogen Bioservices India Private Limited
- Multi-specific antibodies targeting a dimerizable tumor antigen and an immunostimulatory antigen27 Aug 2026US 2026/0250395 A1Chimagen Biosciences, Ltd.
- Mutant of antibody variable region, and use thereof27 Aug 2026US 2026/0250416 A1
- Bispecific polypeptide molecule13 Aug 2026US 2026/0234265 A1Enara Bio Limited
- Modification of anti-pd-1 antibodies to treat cancer30 Jul 2026US 2026/0217829 A1The Trustees of Columbia University in the City of New York
Most cited
By later US patents
- Biosynthetic antibody binding sites621US 5,091,513 ACreative BioMolecules, Inc. · 1992
- Polypeptide linkers for production of biosynthetic proteins555US 5,258,498 ACreative BioMolecules, Inc. · 1993
- Cysteine engineered antibodies and conjugates485US 7,521,541 B2Genetech, Inc. · 2009
- Biosynthetic antibody binding sites393US 5,132,405 ACreative BioMolecules, Inc. · 1992
- Method for making multispecific antibodies having heteromultimeric and common components266US 7,183,076 B2Genentech, Inc. · 2007